Join a powerful, unprecedented alliance for better eye health for all.
Join IAPB
The prevalence of myopia in premature children with or without treatment for ROP is significantly higher than in full-term children. This lecture will explore the dynamics of myopia development in both treated and untreated cases of ROP. This lecture will elaborate on myopia development and evaluate the associated factors in preterm infants treated with anti-VEGF (Intravitreal Bevacizumab) or laser photocoagulation. The latest research findings, clinical insights, and potential strategies to mitigate myopia in the context of ROP will be discussed. (Level: Intermediate)
Lecturer: Dr. Neelam Pawar, Ophthalmologist, Aravind Eye Hospital/University of Michigan, USA
Rwanda
Indonesia
United States
Australia
United Arab Emirates
